Melatonin and 6-sulfatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: Evidence for reduced pineal activity and relevance of urinary determinations
References (42)
- et al.
Inhibition of Dunning tumor growth by melatonin
J Urol
(1988) - et al.
Metabolism of exogenous melatonin in schizophrenic and nonschizophrenic volunteers
Clin Chim Acta
(1969) - et al.
The fate of melatonin in animals
J Biol Chem
(1961) Melatonin excretion in normal males and females: increase during puberty
Metabolism
(1982)Clinical significance of melatonin
Progr Brain Res
(1979)- et al.
High prevalence of benign prostatic hypertrophy in the community
Lancet
(1991) - et al.
A simplified radioimmunoassay for melatonin and its application to biological fluids. Preliminary observations on the half-life of plasma melatonin in man
Clin Chim Acta
(1978) - et al.
Effect of melatonin on experimental tumors under different photoperiods and times of administration
J Neural Transm
(1981) - et al.
Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat
Cancer Res
(1981) - et al.
Effects of growing tumors on pineal melatonin levels in male rats
J Neural Transm
(1981)
Pineal melatonin synthesis and secretion during induction and growth of mammary cancer in female rats
Urinary melatonin levels in human breast cancer patients
J Neural Transm
Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer
Science
Stage-dependent depression of melatonin in patients with primary breast cancer: Correlation with prolactin, thyroid stimulating hormone and steroid receptors
Cancer
Circadian rhythms of serum melatonin, prolactin and growth hormone in patients with benign and malignant tumors of the prostate and in non-tumor controls
Neuroendocrinol Lett
Evidence for modulation of melatonin secretion in men with benign and malignant tumors of the prostate: relationship with the pituitary hormones
J Pineal Res
Diurnal melatonin excretion in gastric and rectal cancer patients
Vop Onkol SSSR
Plasma melatonin levels in patients suffering from colorectal carcinoma
J Pineal Res
Ontogeny of melatonin metabolism in the rat
Effect of the mammary carcinogen 7,12-dimethylbenz[a]anthracene on pineal melatonin biosynthesis, secretion and peripheral metabolism
Neuroendocrinology
Depression of serum melatonin in patients with primary breast cancer is not due to an increased peripheral metabolism
Cancer
Cited by (105)
Physiological melatonin levels in healthy older people: A systematic review
2016, Journal of Psychosomatic ResearchCitation Excerpt :The maximum levels varied greatly. ( See Fig. 2) Mazzoccoli [10,39] showed peak levels of approximately 90 pg ml− 1, 3 studies [26,27,9] showed maximum levels around 60 pg ml− 1 and the lowest maximum level was found by Iguichi, 11.2 pg ml− 1. [41] In Fig. 3 the (weighted) mean melatonin concentration in twenty-four hours is presented.
Geographically-weighted regression analysis of percentage oflate-stage prostate cancer diagnosis in Florida
2015, Applied GeographyCitation Excerpt :An important factor associated with high percentage of late-stage PCa is the presence and severity of comorbidity. Comorbidity is the co-occurrence of one or more diseases or disorders in an individual (Bartsch et al., 1992; Siu, Lau, Tam, & Shiu, 2002). Comorbidity reflects the aggregate effect of all clinical conditions a patient might have, excluding the disease of primary interest (Arcangeli, Smith, Ratliff, & Catalona, 1997).
Urinary melatonin levels, sleep disruption, and risk of prostate cancer in elderly men
2015, European UrologyCircadian rhythm in prostate cancer: time to take notice of the clock
2023, Asian Journal of AndrologyAssessing the Sleep-wake Pattern in Cancer Patients for Predicting a Short Sleep Onset Latency
2022, Clinical Psychopharmacology and NeuroscienceImpact of Circadian Rhythms on the Development and Clinical Management of Genitourinary Cancers
2022, Frontiers in Oncology
- ∗
Present address: Section of Clinical Pharmacology, Department of Gynecology, University of Tübingen, W-7400 Tübingen, Germany.